# US 2001/0025049 A1 · Heterocyclic compounds and their therapeutic use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0025049 A1
- Document ID: US20010025049A1
- Status: Published application
- Kind: A1
- Application number: 09/822,071
- Filed: 2001-03-30
- Published: 2001-09-27
- Earliest claimed: 1998-11-04
- Assignees: Darwin Discovery, Ltd.
- Inventors: Hazel Joan Dyke; John Gary Montana
- Web page: https://patentgrep.com/patent/US20010025049A1

## CPC

- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

N-oxides of formula (i) 1 wherein R1 is CH3, CH2F, CHF2 or CF3; R2 is CH3 or CF3; R3 is F, Cl, Br, CN or CH3; and R4 is H, F, Cl, Br, CN or CH3; and pharmaceutically-acceptable salts thereof, are useful as therapeutic agents, e.g., for the treatment of inflammatory diseases.

## Claims

### Claim 1

A method for the treatment of a disease state that is capable of being modulated by inhibition of phosphodiesterase IV or Tumour Necrosis Factor, or that is a pathological condition associated with a function of phosphodiesterase IV, eosinophil accumulation or a function of the eosinophil, said method comprising administering to a person or animal an effective amount of the compound of formula (i) 3
wherein
R1 is CH3, CH2F, CHF2 or CF3;
R2 is CH3 or CF3;
R3 is F, Cl, Br, CN or CH3; and
R4 is H, F, Cl, Br, CN or CH3;
or a pharmaceutically-acceptable salt thereof.

### Claim 2 (depends on 1)

The method of claim 1, wherein the disease state is an inflammatory disease or autoimmune disease.

### Claim 3 (depends on 1)

The method of claim 1, wherein the disease state is selected from the group consisting of chronic bronchitis, chronic pulmonary inflammatory disease, atopic dermatitis, allergic rhinitis, psoriasis, arthritis, rheumatoid arthritis, joint inflammation, ulcerative colitis, Crohn's disease, atopic eczema, stroke, bone resorption disease, multiple sclerosis and inflammatory bowel disease.

### Claim 4 (depends on 1)

The method of claim 1, wherein the disease state is selected from the group consisting of urticaria, allergic conjunctivitis, vernal conjunctivitis, inflammation of the eye, allergic responses in the eye, eosinophilic granuloma, gouty arthritis and other arthritic conditions, adult respiratory distress syndrome, diabetes insipidus, keratosis, cerebral senility, multi-infarct dementia, senile dementia, memory impairment associated with Parkinson's disease, depression, cardiac arrest, intermittent claudication, rheumatoid spondylitis, osteoarthritis, sepsis, septic shock, endotoxic shock, gram negative sepsis, toxic shock syndrome, acute respiratory distress syndrome, cerebral malaria, silicosis, pulmonary sarcoidosis, reperfusion injury, graft vs host reaction, allograft rejection, infection-related fever or myalgia, malaria, HIV, AIDS, ARC, cachexia, keloid formation, scar tissue formation, pyresis, systemic lupus erythematosus, type 1 diabetes mellitus, Bechet's disease, anaphylactoid purpura nephritis, chronic glomerulonephritis, leukaemia, tarditive dyskinesia, yeast or fungal infection, conditions requiring gastroprotection, and neurogenic inflammatory disease associated with irritation and pain.

### Claim 5 (depends on 2)

The method of claim 2, wherein the disease state is chronic bronchitis.

### Claim 6 (depends on 1)

The method of claim 1, wherein the compound is 8-methoxy-2-trifluoromethylquinoline-5-carboxylic acid (3,5-dichloro-1-oxypyridin-4-yl)amide.

### Claim 7 (depends on 2)

The method of claim 2, wherein the compound is 8-methoxy-2-trifluoromethylquinoline-5-carboxylic acid (3,5-dichloro-1-oxypyridin-4-yl)amide.

### Claim 8 (depends on 3)

The method of claim 3, wherein the compound is 8-methoxy-2-trifluoromethylquinoline-5-carboxylic acid (3,5-dichloro-1-oxypyridin-4-yl)amide.

### Claim 9 (depends on 4)

The method of claim 4, wherein the compound is 8-methoxy-2-trifluoromethylquinoline-5-carboxylic acid (3,5-dichloro- 1-oxypyridin-4-yl)amide.

### Claim 10 (depends on 5)

The method of claim 5, wherein the compound is 8-methoxy-2-trifluoromethylquinoline-5 -carboxylic acid (3,5-dichloro-1-oxypyridin-4-yl)amide.
